Viviane M Andrade (V M Andrade)

Years Active: 2020-2023
Publications (10 Years): 3

Inovio Pharmaceuticals Inc

University of Miami Health System (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Inovio Pharmaceuticals Inc Feb 03 2020

United States

Scientist

University of Miami Health System Aug 18 2014 - Jan 31 2020

United States

PhD candidate :: Medicine

Education History

University of Miami Health System Aug 18 2014 - Jan 31 2020

United States

PHD :: Molecular Cell Biology

Publications

Viviane M Andrade, Igor Maricic, Richa Kalia, Lauren Jachimowicz, Olivia Bedoya, Daniel W Kulp, Laurent Humeau, Trevor R F Smith
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models. Human vaccines & immunotherapeutics 19 (3) (2023)
S Mediouni, J A Jablonski, S Tsuda, A Barsamian, C Kessing, A Richard, A Biswas, F Toledo, Viviane M Andrade, Y Even, M Stevenson, T Tellinghuisen, H Choe, M Cameron, T D Bannister, S T Valente
Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells. Journal of virology 94 (15) (2020)
Viviane M Andrade, Carla N Mavian, Dunja Babic, Thaissa Cordeiro, Mark Sharkey, Labelle Barrios, Christian Brander, Javier Martínez Picado, Judith Dalmau, Anuska Llano, Jonathan Z Li, Jeffrey Jacobson, Christy L Lavine, Michael S Seaman, Marco Salemi, Mario Stevenson
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption. Proceedings of the National Academy of Sciences of the United States of America 117 (18) (2020)

Viviane M Andrade.css-eqlu8i{font-size:small;padding-left:4px;} (V M Andrade)